National Pharmacy Benefit Manager, WellDyneRx®, Adds CellerateRX® to Its Health and Wellness Products

FORT WORTH, Texas, June 3, 2011 /PRNewswire/ -- Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leader in advanced wound care solutions, today announced that WellDyneRx, a national pharmacy benefit management company (PBM), has become a distributor of its CellerateRX® line of wound care products.  WellDyneRx is a division of WellDyne, Inc., a provider of a range of health services including Pharmacy Benefit Management, Mail Order Pharmacy, Specialty Drug Fulfillment and online access to a broad range of information on health, disease, pharmaceuticals and wellness.

"WellDyneRx is excited to partner with Wound Management Technologies in the distribution of CellerateRX, an innovative product that offers unprecedented performance and cost savings in wound care.  WellDyneRx is committed to providing the highest quality of care while delivering measurable savings through cost containment," said Doug Taylor, Executive Vice-President for WellDyneRx.

Deborah Jenkins Hutchinson, President of Wound Management Technologies, spoke of the role national pharmacy benefit management companies play within the US healthcare system, "PBMs are an integral part of the healthcare system today. They work with their clients to provide their members with quality healthcare solutions in a cost effective system.  Our distribution agreement with WellDyneRx will make CellerateRX accessible to millions of potential patients to treat diabetic ulcers, burns, surgical wounds, and more."    

About Wound Management Technologies, Inc.

Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market. Wound Management's primary focus is the distribution of its unique, patented collagen product, CellerateRX®, which is FDA cleared and reimbursable under Medicare Part B. Wound Management has other advanced biotech products in development including a patented resorbable bone wax line that is in late stages of development, as well as a subsidiary focused on technology for secure healthcare data collaboration and storage.  More information can be found on the company's web sites: http://www.wmgtech.com and http://www.celleraterx.com.

Follow us on: FACEBOOK | TWITTER | LINKEDIN

About WellDyneRx

WellDyneRx is a national pharmacy benefit management company that serves its health plan members through a retail network of over 64,000 nationwide pharmacies and a full-service mail order facility that utilizes state-of-the-art robotics technology to quickly and accurately fill prescriptions.  WellDyneRx serves the needs of over 6 million Americans through Third Party Administrators, Government Organizations, Union Groups, Hospitals and Health Clinics, Self-funded Employer Groups, Managed Care Organizations, and Medicare Plans.  For more information, visit the company's website at www.welldynerx.com.

Safe Harbor Statement:

The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

For Wound Management Technologies Shareholder Information please call (917) 974-9872 or visit http://www.wmgtech.com

SOURCE Wound Management Technologies, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED